UnitedHealth Raises 2026 Adjusted Earnings Guidance to at Least $20.50
UnitedHealth raised its full-year 2026 adjusted earnings guidance to at least $20.50 per share, from a previous range of $19.50 to $20. Third-quarter earnings were described as stronger than expected.
UnitedHealth Group Inc. (NYSE: UNH) reported third-quarter earnings that exceeded expectations and lifted its full-year 2026 outlook, drawing attention from investors following healthcare-sector ETFs. 50 to $20. 86.
The results may affect sentiment toward healthcare stocks. The impact on ETFs will depend on UnitedHealth’s portfolio weighting, how other holdings perform and whether its improved profitability is sustained. Also read: UnitedHealth Stock Wobbles Despite 61% Profit Jump, Boosted Outlook XLV, IHF and VHT: How Much UNH Exposure Do Investors Get? S.
healthcare companies, including pharmaceutical manufacturers, insurers and medical-device makers. 43% of XLV’s portfolio. S. Healthcare Providers ETF (NYSE: IHF) focuses more narrowly on healthcare providers and insurers.
48% of the fund’s holdings, leaving its performance much more exposed to movements in UNH shares. 89% of its portfolio invested in UnitedHealth, alongside hundreds of other healthcare companies. IHF therefore offers more concentrated exposure to UnitedHealth’s recovery, while XLV and VHT distribute investments across a wider range of healthcare businesses. Medical costs remain a key risk.
9% a year earlier. 5%. The MCR decline included $610 million in favorable development of reserves from prior periods. That benefit should be distinguished from recurring operating improvements when evaluating whether the insurer can sustain higher earnings.
Results across the company’s underlying businesses were mixed. 9 billion. 5 billion. 9 billion.
Healthcare ETF investors will next watch whether better cost management supports sustained earnings growth without further weakening in UnitedHealth’s insurance and healthcare-services operations. The higher guidance gives investors a new reason to assess healthcare ETF exposure. The difference between concentrated UNH exposure through IHF and broader diversification via XLV and VHT remains central. Related reading: UnitedHealth says Wall Street may be underestimating its 2027 earnings potential.